Literature DB >> 27788906

Autologous Conditioned Serum.

Christopher H Evans1, Xavier Chevalier2, Peter Wehling3.   

Abstract

Autologous conditioned serum was developed in the mid 1990s as an expeditious, practical, and relatively inexpensive means of generating the interleukin-1 receptor antagonist, a naturally occurring inhibitor of the cytokine interleukin-1. The latter is thought to be an important mediator of inflammation, pain, and tissue destruction in musculoskeletal conditions. ACS has been widely and successfully used in the local treatment of human and equine osteoarthritis and radicular compression; it has also shown promise in treating tendinopathies, muscle injuries, and tunnel widening after reconstruction of the anterior cruciate ligament. Experience suggests that autologous conditioned serum is safe and effective.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anterior cruciate ligament; Interleukin-1 receptor antagonist; Intra-articular therapy; Muscle injury; Osteoarthritis; Pain; Radicular compression; Tendinopathy

Mesh：

Substances：

Year:  2016        PMID： 27788906     DOI： 10.1016/j.pmr.2016.06.003

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN： 1047-9651            Impact factor:   1.784


  12 in total

Review 1.  Neuroimmune modulation of pain and regenerative pain medicine.

Authors:  Thomas Buchheit; Yul Huh; William Maixner; Jianguo Cheng; Ru-Rong Ji
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 2.  Cell Therapy-a Basic Science Primer for the Sports Medicine Clinician.

Authors:  Bijan Dehghani; Scott Rodeo
Journal:  Curr Rev Musculoskelet Med       Date:  2019-12

Review 3.  Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain.

Authors:  Teemu V Karjalainen; Michael Silagy; Edward O'Bryan; Renea V Johnston; Sheila Cyril; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2021-09-30

4.  Platelet Rich Plasma Versus Autologous Conditioned Serum in Osteoarthritis of the Knee: Clinical Results of a Five-Year Retrospective Study.

Authors:  Hüseyin Sina Coşkun; Alparslan Yurtbay; Ferhat Say
Journal:  Cureus       Date:  2022-04-26

5.  Comparison on effects of platelet-rich plasma versus autologous conditioned serum on Achilles tendon healing in a rat model.

Authors:  Erdinç Genç; Serdar Yüksel; Aysel Çağlar; Ozan Beytemur; M Akif Güleç
Journal:  Acta Orthop Traumatol Turc       Date:  2020-07       Impact factor: 1.511

6.  Intra-Articular Injections of Autologous Conditioned Serum to Treat Pain from Meniscal Lesions.

Authors:  Rudolf Strümper
Journal:  Sports Med Int Open       Date:  2017-09-29

Review 7.  The Diagnosis and Therapy of Degenerative Knee Joint Disease: Expert Consensus from the Chinese Pain Medicine Panel.

Authors:  Dong Huang; Yan-Qing Liu; Li-Shuang Liang; Xue-Wu Lin; Tao Song; Zhi-Gang Zhuang; Suo-Liang Wang; Hong-Guang Bao; Lin Wang; Xian-Wei Zhang; Zhi-Gang Cheng; Bao-Lin Duan; Wei-Dong Qiu; Yuan-Chang Xiong; Jin-Feng Liu
Journal:  Pain Res Manag       Date:  2018-12-13       Impact factor: 3.037

Review 8.  Effectiveness of intra-articular autologous-conditioned serum injection in knee osteoarthritis: a meta-analysis study.

Authors:  Seyed A Raeissadat; Seyed M Rayegani; Mohammad R Sohrabi; Nafisseh Jafarian; Mohammad N Bahrami
Journal:  Future Sci OA       Date:  2021-10-11

9.  Investigation of the biomechanical and histopathological effects of autologous conditioned serum on healing of Achilles tendon.

Authors:  Erdinç Genç; Ozan Beytemur; Serdar Yuksel; Yılmaz Eren; Aysel Çağlar; Bedri Onur Küçükyıldırım; Mehmet Akif Güleç
Journal:  Acta Orthop Traumatol Turc       Date:  2018-02-15       Impact factor: 1.511

10.  Autologous conditioned serum: clinical and functional results using a novel disease modifying agent for the management of knee osteoarthritis.

Authors:  Matteo Vitali; Marco Ometti; Andreas Drossinos; Pierluigi Pironti; Luca Santoleri; Vincenzo Salini
Journal:  J Drug Assess       Date:  2020-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.